|
WO2016100564A1
|
|
Liquid dispensing device with electronic counting component
|
|
US2014066411A1
|
|
Pharmaceutical compositions for extended release of azo-bonded 5-aminosalicylic acid compositions
|
|
US2013316002A1
|
|
Compositions and methods for treating gastrointestinal motility dysfunction
|
|
EP2509635A2
|
|
Gastric retentive pharmaceutical compositions for extended release of polypeptides
|
|
US2011104273A1
|
|
Gastric retentive pharmaceutical compositions for immediate and extended release of phenylephrine
|
|
US2011104272A1
|
|
Gastric retentive extended-release dosage forms comprising combinations of acetaminophen and phenylephrine
|
|
AU2010286354A1
|
|
Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
|
|
US2011052700A1
|
|
Gastric retentive pharmaceutical compositions for immediate and extended release of levosulpiride
|
|
US2010196474A1
|
|
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
|
CN102202656A
|
|
Gastric retentive pharmaceutical compositions for treatment and prevention of cns disorders
|
|
US2010015222A1
|
|
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
|
WO2009102734A1
|
|
Methods for treating vasomotor symptoms using gaba analogs in a gastric retentive dosage form
|
|
US2009176882A1
|
|
Gastric retentive gabapentin dosage forms and methods for using same
|
|
AU2008282900A1
|
|
Pulsatile gastric retentive dosage forms
|
|
US2007184104A1
|
|
Gastric retentive gabapentin dosage forms and methods for using same
|
|
CA2635466A1
|
|
Gastric retentive gabapentin dosage forms and methods for using same
|
|
US2006159743A1
|
|
Methods of treating non-nociceptive pain states with gastric retentive gabapentin
|
|
US7612112B2
|
|
Methods of treatment using a gastric retained gabapentin dosage
|
|
MXPA06000526A
|
|
Dual drug dosage forms with improved separation of drugs.
|
|
MXPA04003929A
|
|
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data.
|
